Raloxifene hydrochloride drug description, Exporters, Importers, drug description, Molecular Formula C28H27NO4S.HCl;C28H28ClNO4S, Molecular Weight 510.05, CAS Registry Number 82640-04-8, drugs Suppliers, Uses, Generic Products, Distributors, Side Effects, bulk drugs, Anti-Bacterial, Warnings, Raloxifene hcl Distributors, api, active pharmaceuticals ingredients, Information Drugs, Importers, drug Technology, FDA, hydrochloride, Taj Pharmaceuticals LTd.

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Raloxifene Hcl Taj Pharmaceticals Ltd.

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Raloxifene Hcl Manufacturers in India Suppliers Raloxifene Hcl Exporters Distributors Raloxifene Hcl api active pharmaceuticals ingredients Raloxifene Hcl manufacturers Side Effects bulk drugs raw material Raloxifene Hcl companies Side Effects Importers Raloxifene Hcl Raloxifene Hcl Exporters Raloxifene Hcl exporters FDA Raloxifene Hcl DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Raloxifene hydrochloric manufacturing pharmaceutical drugs pharmaceutical intermediates Raloxifene hydrochloric pharmaceutical chemicals pharmaceutical raw materials Raloxifene hydrochloric active pharmaceutical ingredients Raloxifene hydrochloric committee active pharmaceutical ingredients manufacturer Raloxifene hydrochloric Active Pharmaceutical Ingredients manufacturer Raloxifene hydrochloric exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Raloxifene Hcl, Raloxifene Hcl manufacturer India, Raloxifene Hcl product, Raloxifene Hcl products, Api preparation, Certificate of Analysis API manufacturer product, Raloxifene Hcl anti ulcer product, Certificate of Origin COA Raloxifene Hcl COS Raloxifene Hcl, pharmaceutical generic, pharmaceutical drug, medical, Raloxifene Hcl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Raloxifene Hcl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Raloxifene Hcl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Raloxifene Hcl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Raloxifene Hcl ingredients, api, HIV Raloxifene Hcl, tablets, capsules, syrup & protein Raloxifene Hcl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Raloxifene Hcl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Raloxifene Hcl WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

HOME >> API >> API List 3 >> Raloxifene Hcl >> Drug Description

Raloxifene Hcl

DRUG DESCRIPTION
Raloxifene Hcl CAS Number 82640-04-8

Raloxifene HCl is an off-white to pale-yellow solid that is very slightly soluble in water.

Raloxifene HCl is supplied in a tablet dosage form for oral administration. Each Raloxifene HCl tablet contains 60 mg of raloxifene HCl, which is the molar equivalent of 55.71 mg of free base. Inactive ingredients include anhydrous lactose, carnauba wax, crospovidone, FD&C Blue No. 2 aluminum lake, hypromellose, lactose monohydrate, magnesium stearate, modified pharmaceutical glaze, polyethylene glycol, polysorbate 80, povidone, propylene glycol, and titanium dioxide.

EVISTA is the only medicine proven to reduce both the risk of spinal fractures due to osteoporosis and the risk of invasive breast cancer in postmenopausal women with osteoporosis. EVISTA does not treat breast cancer, prevent it from returning, or reduce the risk of all forms of breast cancer.

Raloxifene is prescribed to treat postmenopausal women for osteoporosis.Raloxifene uses are primarily concerned with both osteoporosis and breast cancer. This page of the eMedTV Web site explains why raloxifene is used for both conditions, how it works in the body, and also addresses off-label uses and uses in children.

Information Associated with Product:

DRUG DESCRIPTION >>

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.